Biologically active thymones from the thymus
AssigneeBoard of Reagents, The University of Texas System
InventorsKarl Folkers, Teresa M. Kubiak, Henryk M. Stepien, Naoki Sakura
Life of this patent
Estimating the term…
Loading patent…
AssigneeBoard of Reagents, The University of Texas System
InventorsKarl Folkers, Teresa M. Kubiak, Henryk M. Stepien, Naoki Sakura
Estimating the term…
A class of three substances has been isolated in highly purified form and in substantially pure form by utilizing thymus tissue as a source material. These three substances are designated thymone A, thymone B and thymone C. Thymones A and B are new peptides which yield approximately 13 and 14 individual amino acid moieties, respectively, on acid hydrolysis. Thymones A and B are chemically characterized by electrophoretic and chromatographic values which are appropriate for substances which are substantially pure. Thymone C was highly purified and its biological activity was reproducibly detected and measured. Thymones A, B and C stimulate the proliferation of lymphocytes. Thymone A stimulates the formation of cyclic adenosine monophosphate. Thymone B stimulates the formation of cyclic guanosine monophosphate. The biological activities of these thymones to stimulate the proliferation of lymphocytes and the formations of cyclic nucleotides are basic hormonal functions for the therapeutic enhancement of the immune system in patients who have immune deficiencies from diverse causes.
A class of biologically active substances from thymus tissue consisting essentially of thymone A, having
A biologically active substance extracted from thymus tissue consisting essentially of thymone A, having
A biologically active substance extracted from thymus tissue consisting essentially of thymone B, having
A biologically active substance extracted from thymus tissue consisting essentially of thymone C,
Dependencies are inferred from the claim text.